Publications by authors named "Jonathan Schoenfeld"

82Publications

Clinical Decision-Making About Neoadjuvant Nivolumab Plus Ipilimumab-Reply.

JAMA Oncol 2020 Dec 23. Epub 2020 Dec 23.

Brigham and Women's Hospital, Boston, Massachusetts.

View Article and Find Full Text PDF
December 2020

Reply to "Keynote 48: Is it really for everyone?"

Oral Oncol 2020 Dec 1:105108. Epub 2020 Dec 1.

Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States.

View Article and Find Full Text PDF
December 2020

Hospitalization rates and 30-day all-cause mortality among head and neck cancer patients and survivors with COVID-19.

Oral Oncol 2021 01 6;112:105087. Epub 2020 Nov 6.

Dana-Farber Cancer Institute, Center for Head & Neck Oncology, Boston, MA; Department of Surgery, Division of Otolaryngology-Head & Neck Surgery, Brigham & Women's Hospital, Boston, MA.

View Article and Find Full Text PDF
January 2021

Association between treatment center experience and survival after diagnosis of stage I to III Merkel cell carcinoma treated with surgery with or without postoperative radiation therapy.

J Am Acad Dermatol 2020 Nov 7. Epub 2020 Nov 7.

Department of Radiation Oncology, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts; Merkel Cell Carcinoma Center of Excellence, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address:

View Article and Find Full Text PDF
November 2020

Keynote 48: Is it really for everyone?

Oral Oncol 2020 06 4;105:104762. Epub 2020 May 4.

Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States.

View Article and Find Full Text PDF
June 2020

Long-term outcomes and clinicogenomic correlates in recurrent, metastatic adenoid cystic carcinoma.

Oral Oncol 2020 07 11;106:104690. Epub 2020 Apr 11.

Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA; BC Cancer, Vancouver Centre, 600 West 10th Avenue, Vancouver, BC V5Z 4E6, Canada.

View Article and Find Full Text PDF
July 2020

PACIFIC: shifting tides in the treatment of locally advanced non-small cell lung cancer.

Transl Lung Cancer Res 2019 Sep;8(Suppl 2):S139-S146

Department of Radiation Oncology, Princess Margaret Cancer Centre/University of Toronto, Toronto, ON, Canada.

View Article and Find Full Text PDF
September 2019

Immunotherapy and Radiation: Charting a Path Forward Together.

Hematol Oncol Clin North Am 2019 12 17;33(6):1057-1069. Epub 2019 Sep 17.

Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, 75 Francis Street, L2, Boston, MA 02115, USA. Electronic address:

View Article and Find Full Text PDF
December 2019

Oral immune-related adverse events associated with PD-1 inhibitor therapy: A case series.

Oral Dis 2020 Mar 9;26(2):325-333. Epub 2020 Jan 9.

Department of Oral Medicine, Infection, and Immunity, Harvard School of Dental Medicine, Boston, MA, USA.

View Article and Find Full Text PDF
March 2020

Lessons Learned from Deescalation Trials in Favorable Risk HPV-Associated Squamous Cell Head and Neck Cancer-A Perspective on Future Trial Designs.

Clin Cancer Res 2019 12 16;25(24):7281-7286. Epub 2019 Sep 16.

Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article and Find Full Text PDF
December 2019

Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United States.

Cancer Epidemiol Biomarkers Prev 2019 10 29;28(10):1660-1667. Epub 2019 Jul 29.

Department of Radiation Oncology, Head and Neck Oncology Program, Dana-Farber Cancer Institute, Brigham and Women's Cancer Center, Boston, Massachusetts.

View Article and Find Full Text PDF
October 2019

Palliative Radiation Therapy for Vertebral Metastases and Metastatic Cord Compression in Patients Treated With Anti-PD-1 Therapy.

Front Oncol 2019 29;9:199. Epub 2019 Mar 29.

Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.

View Article and Find Full Text PDF
March 2019

Radiation Therapy and Immune Modulation.

Hematol Oncol Clin North Am 2019 04 17;33(2):233-248. Epub 2019 Jan 17.

Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women's Hospital, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address:

View Article and Find Full Text PDF
April 2019

We Are All Connected: Modeling the Tumor-Immune Ecosystem.

Trends Cancer 2018 10 13;4(10):655-657. Epub 2018 Sep 13.

Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02215, USA. Electronic address:

View Article and Find Full Text PDF
October 2018

Denaturation-Enhanced Droplet Digital PCR for Liquid Biopsies.

Clin Chem 2018 12 1;64(12):1762-1771. Epub 2018 Oct 1.

Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA;

View Article and Find Full Text PDF
December 2018

Radiologic predictors of immune checkpoint inhibitor response in advanced head and neck squamous cell carcinoma.

Oral Oncol 2018 10 17;85:29-34. Epub 2018 Aug 17.

Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA 703-389-1895, United States. Electronic address:

View Article and Find Full Text PDF
October 2018

Immunotherapy and radiotherapy for metastatic cancers.

Ann Palliat Med 2019 Jul 22;8(3):312-325. Epub 2018 Aug 22.

Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA, USA.

View Article and Find Full Text PDF
July 2019

Funding Support and Principal Investigator Leadership of Oncology Clinical Trials Using Radiation Therapy.

Int J Radiat Oncol Biol Phys 2018 09 22;102(1):34-43. Epub 2018 May 22.

Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address:

View Article and Find Full Text PDF
September 2018

Stereotactic Ablative Radiation Therapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site.

Int J Radiat Oncol Biol Phys 2018 08 22;101(5):1259-1270. Epub 2018 Apr 22.

Department of Radiation Oncology, University of California, Davis, Comprehensive Cancer Center, Davis, California; Laboratory of Cancer Immunology, University of California, Davis, School of Medicine, Davis, California.

View Article and Find Full Text PDF
August 2018

Evaluating the potential for maximized T cell redistribution entropy to improve abscopal responses to radiotherapy.

Converg Sci Phys Oncol 2017 Sep 15;3(3). Epub 2017 Jun 15.

Department of Integrated Mathematical Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

View Article and Find Full Text PDF
September 2017

Using immunotherapy to boost the abscopal effect.

Nat Rev Cancer 2018 05 16;18(5):313-322. Epub 2018 Feb 16.

Department of Radiation Oncology, Weill Cornell Medicine, 1300 York Avenue, Box 169, New York, NY, USA.

View Article and Find Full Text PDF
May 2018

Prospective analysis of radiation oncology image and plan-driven peer review for head and neck cancer.

Head Neck 2017 08 17;39(8):1603-1608. Epub 2017 May 17.

Department of Radiation Oncology, Dana-Farber / Brigham and Women's Cancer Center, 450 Brookline Avenue, Boston, Massachusetts.

View Article and Find Full Text PDF
August 2017

Multicenter Evaluation of the Tolerability of Combined Treatment With PD-1 and CTLA-4 Immune Checkpoint Inhibitors and Palliative Radiation Therapy.

Int J Radiat Oncol Biol Phys 2017 06 11;98(2):344-351. Epub 2017 Feb 11.

Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address:

View Article and Find Full Text PDF
June 2017

Merkel Cell Carcinoma: A Population Analysis on Survival.

J Natl Compr Canc Netw 2016 10;14(10):1247-1257

From Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School; Department of Radiation Oncology, and Department of Medical Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute; and Merkel Cell Carcinoma Clinic, Department of Dermatology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.

View Article and Find Full Text PDF
October 2016

Effects of definitive chemoradiation on circulating immunologic angiogenic cytokines in head and neck cancer patients.

J Immunother Cancer 2016 21;4:32. Epub 2016 Jun 21.

Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Center, 450 Brookline Ave, DA L2-57, Boston, MA 02114 USA.

View Article and Find Full Text PDF
June 2016

Population-based validation of the recursive partitioning analysis-based staging system for oropharyngeal cancer.

Head Neck 2016 10 15;38(10):1530-8. Epub 2016 Apr 15.

Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts.

View Article and Find Full Text PDF
October 2016

Synchronous squamous cell carcinoma and diffuse large B-cell lymphoma of the head and neck: the odd couple.

BJR Case Rep 2016 19;2(1):20150271. Epub 2016 Jan 19.

Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA, USA.

View Article and Find Full Text PDF
January 2016

Radiation dose and checkpoint blockade immunotherapy: unanswered questions.

Lancet Oncol 2016 Jan 23;17(1):e3-4. Epub 2015 Dec 23.

Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Center, Boston, MA, 02114, USA. Electronic address:

View Article and Find Full Text PDF
January 2016

A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab.

Oncoimmunology 2015 Nov 28;4(11):e1046028. Epub 2015 May 28.

Department of Radiation Oncology; Brigham and Women's Hospital/Dana-Farber Cancer Institute ; Boston, MA USA.

View Article and Find Full Text PDF
November 2015

Immune effects of targeted radiation therapy for cancer.

Discov Med 2015 Mar;19(104):219-28

Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.

View Article and Find Full Text PDF
March 2015

Ensuring head and neck oncology patients receive recommended pretreatment dental evaluations.

J Oncol Pract 2015 Mar 27;11(2):151-4. Epub 2015 Jan 27.

Brigham and Women's Hospital; Dana-Farber Cancer Institute; Center for Clinical Excellence, Brigham and Women's Hospital, Boston, MA; and Center for Oncology Care at Erie County Medical Center, Buffalo, NY.

View Article and Find Full Text PDF
March 2015

Immunity in head and neck cancer.

Cancer Immunol Res 2015 Jan;3(1):12-7

Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article and Find Full Text PDF
January 2015

The Impact of Positive Margins on Outcome Among Patients With Gastric Cancer Treated With Radiation.

Am J Clin Oncol 2016 06;39(3):243-7

Departments of *Radiation Oncology ∥Medical Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute Departments of †Radiation Oncology ‡Medical Oncology §Surgical Oncology, Massachusetts General Hospital, Boston, MA.

View Article and Find Full Text PDF
June 2016

Is everything we eat associated with cancer? A systematic cookbook review.

Am J Clin Nutr 2013 Jan 28;97(1):127-34. Epub 2012 Nov 28.

Harvard Radiation Oncology Program, Harvard Medical School, Boston, MA, USA.

View Article and Find Full Text PDF
January 2013

Survival of a patient with anaplastic thyroid cancer following intensity-modulated radiotherapy and sunitinib--a case report.

Anticancer Res 2012 May;32(5):1743-6

Harvard Radiation Oncology Program, and Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.

View Article and Find Full Text PDF
May 2012

Abbreviated course of radiotherapy (RT) for breast cancer.

Breast 2011 Oct;20 Suppl 3:S116-27

Harvard Radiation Oncology Program, Dana-Farher Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA.

View Article and Find Full Text PDF
October 2011

Anti-angiogenesis immunotherapy.

Hum Vaccin 2011 Sep 1;7(9):976-81. Epub 2011 Sep 1.

Harvard Radiation Oncology Program and Harvard Medical School, Boston, MA, USA.

View Article and Find Full Text PDF
September 2011

Active immunotherapy induces antibody responses that target tumor angiogenesis.

Cancer Res 2010 Dec;70(24):10150-60

Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article and Find Full Text PDF
December 2010

Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy.

Int J Radiat Oncol Biol Phys 2012 Jan 13;82(1):308-14. Epub 2010 Nov 13.

Department of Radiation Oncology, Harvard Radiation Oncology Program, Boston, MA 02114, USA.

View Article and Find Full Text PDF
January 2012

PECAM-1 affects GSK-3beta-mediated beta-catenin phosphorylation and degradation.

Am J Pathol 2006 Jul;169(1):314-24

Department of Pathology, Yale University School of Medicine, 310 Cedar St., Lauder Hall, Rm. L115, New Haven, CT 06520, USA.

View Article and Find Full Text PDF
July 2006

Identification of the regions of PECAM-1 involved in beta- and gamma-catenin associations.

Biochem Biophys Res Commun 2005 Apr;329(4):1225-33

Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.

View Article and Find Full Text PDF
April 2005

PECAM-1 promotes beta-catenin accumulation and stimulates endothelial cell proliferation.

Biochem Biophys Res Commun 2003 Mar;303(1):212-8

Department of Medicine, Yale University School of Medicine, New Haven, CT, USA.

View Article and Find Full Text PDF
March 2003